HypoSti.CAR-T Cells (CD73/AXL targeted)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HypoSti.CAR-T Cells (CD73/AXL targeted), covering 2025-04-22 to 2025-04-22. Get the full timeline:
Most recent: Clinical Trial Update: CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]